During this year's event, Siemens will be offering visitors to the congress an extensive theoretical and practical training program on new diagnostic and therapeutic techniques.
The great progress made in medicine during the past few decades has reduced the death rate for cardiac diseases considerably. At the same time, the number of patients with chronic heart diseases such as cardiac insufficiency has been rising, thus increasing healthcare costs. Medical innovations must therefore contribute to cost reduction while at the same time offering a higher quality of health care. In fact, the spectrum of new diagnostic and therapeutic techniques which improve care and can be performed faster as well as in a more patient-friendly manner, has been expanding rapidly.
Innovative methods such as interventional valve therapy require an interdisciplinary collaboration and an integration of techniques from different medical fields. Hybrid operating rooms are just one result of this development. The hybrid OR combines a full-functional cardiac cath lab with a fully equipped operating room. Multidisciplinary teams with cardiologists and cardiac surgeons can thus join forces to perform new types of therapies. Cardiac MR (magnetic resonance tomography) and cardiac CT (computed tomography) offer entirely new insights into the heart, thus providing information on the heart which alters the treatment path for many diseases considerably. These imaging techniques, but also echocardiography and nuclear medicine increasingly enable physicians to offer a more personalized medicine, i.e. to select "the right therapy for the right patient". Furthermore, as so-called "gatekeepers", they help to determine whether cost-intensive therapies such as e.g. the implantation of an ICD (implantable cardioverter/defibrillator) are indicated according to current guidelines.
Such an innovative environment also makes it necessary for physicians to undergo continuing education and training. Siemens Healthcare supports its customers in this regard, and is therefore offering extensive training sessions dealing with innovative techniques in cardiology at this years Congress of the European Society of Cardiology. The topics covered include, for example, cardiovascular CT and MRI, real-time 3D echocardiography and management of heart failure.
Innovation at the ESCSyngo DynaCT Cardiac: 3D imaging in the cathlab
Additional highlights presented at the ESCChange of paradigms in echocardiography: Transthoracic real-time 3D echocardiography within a single heartbeat
With the Acuson SC2000 volume echocardiography system, Siemens showcases the world's first system capable of generating real-time 3D images of the entire heart during a single heartbeat without the need for stitching small cardiac volumes acquired during several heart cycles. This new technology – "echo in a heartbeat" – is one of the greatest innovations in echocardiography since decades. 55 years after echocardiography pioneers Inge Edler and Hellmuth Hertz used Siemens equipment to acquire the first ultrasound images of the heart, real-time 3D echocardiography is now ripe for clinical routine. Due to a completely new transducer technology and an improved system architecture of the Acuson SC2000, the physician obtains an excellent 4D image of the heart, even faster than before, since the system offers automated analysis of the acquired data sets.Coronary CT angiography: highest diagnostic accuracy at an extremely low dose
In the meantime, several clinical studies have confirmed that the Somatom Definition Flash enables cardiac CT with a dose of less than one mSv in over 70 percent of all patients. For example, Stephan Achenbach, Professor of Cardiology at Erlangen-Nuremberg University, reported at this years SCCT congress that he was able to scan the entire heart in 270 milliseconds (ms) with a dose of approx. 0.95 mSv during routine examinations.1Dual energy CT of the heart: Additional information on cardiac perfusion
The current clinical standard for examining myocardial perfusion is SPECT (Single photon emission computed tomography). In a study recently published in the American Journal of Cardiology, myocardial perfusion following an infarct was measured using SPECT, the standard technique as well as dual energy computed tomography (DECT). It showed that DECT correctly identified 96 percent of the permanent myocardial perfusion defects and 88 percent of the reversible myocardial perfusion defects identified with SPECT. DECT compared very well in comparison with SPECT and holds great promise for evaluation of myocardial perfusion.1Magnetic resonance: New functionalities for routine cardiological examinations
With syngo Dynamics 8.0, the corresponding application for remote image viewing will take on a new appearance. The screen display (Look & Feel) and functional sequences will be adapted to the standard workplace. The application offers a high level of performance so treating physicians will be able to conveniently access patient images from almost any location, even at a low network bandwidth.Laboratory diagnostics in cardiology: Troponin test fulfills the most stringent guidelines of cardiology societies
Today, cardiac troponins are the preferred blood markers for diagnosing myocardial infarction. Siemens was the first company to develop a fully automatic, high-precision and highly sensitive troponin test ("TnI Ultra"), which fulfilled the stringent requirements of the ESC and ACC (European Society of Cardiology/American College of Cardiology). Siemens’ TnI Ultra enables an earlier and better identification of infarct patients. Since this troponin test has already been successfully used on the fully automatic "Advia Centaur" immunoassay systems from Siemens Healthcare, it is now also available for the new, integrated Dimension EXL analysis system from Siemens Healthcare.
Dimension EXL provides both clinical chemical and immunodiagnostic parameters on a single platform. This integrated architecture enables parallel processing of the corresponding assays, thus increasing laboratory productivity. In addition to routine and special diagnostics, the parameter menu also includes therapeutic medication monitoring from immune suppressives to drug screening. Using the LOCI (luminescent oxygen channeling immunoassay) module, innovative chemoluminescence technology can be used to supply highly sensitive analysis results in an especially short time.Fast diagnosis of heart failure: NT-proBNP/BNP test
1 Achenbach et al. Sub-mSv Coronary CT Angiography Using Prospectively ECG-Triggered High-Pitch Spiral Acquisition, SCCT 2009 proceedings, 17.07.09
2 Ruzsics B et al. Comparison of dual-energy computed tomography of the heart with single photon emission computed tomography for assessment of coronary artery stenosis and of the myocardial blood supply. Am J Cardiol. 2009 Aug 1;104(3):318-26.
The Siemens Healthcare Sector is one of the largest suppliers of healthcare technology worldwide. The company is a medical solution provider with core competences and innovative strengths in diagnostic and therapeutic technologies as well as knowledge processing, including information technology and system integration. With its acquisitions in laboratory diagnostics, Siemens Healthcare is the first integrated healthcare company that combines imaging and lab diagnostics, therapy solutions and medical information technology and also supplements these with consultation and services. Siemens Healthcare offers solutions for the entire supply chain under one roof - from prevention and early detection to diagnosis and to treatment and aftercare. In addition, Siemens Healthcare is the global brand leader for innovative hearing aids. Siemens Healthcare currently has around 49,000 employees worldwide and is represented in more than 130 countries. During fiscal 2008 (ending on September 30), Siemens Healthcare achieved a total sales volume of € 11.17 billion and incoming orders totaling € 11.78 billion. The Group earnings amounted to € 1.23 billion.
Bianca Braun | Siemens Healthcare
Further reports about: > 3D images > Acuson S2000 ABVS > Acuson SC2000 > BNP > CMR > Cardiology > DECT > DynaCT > Dynamic > ESC > EXL > Healthcare > IQ•SPECT > NT-proBNP/BNP > SC2000 > SCCT > SPECT > Somatom > cardiac > computed tomography > diagnostic accuracy > heart disease > heart failure > imaging techniques > information technology > magnetic resonance > magnetic resonance tomograph > single photon > single photon emission computed tomography > syngo Dynamics
“Laser Technology Live” at the AKL’18 International Laser Technology Congress in Aachen
23.02.2018 | Fraunhofer-Institut für Lasertechnik ILT
Empa shows "Gas station of the future"
23.02.2018 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt
A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.
In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...
A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.
By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...
Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...
For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.
In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...
Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale
Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...
15.02.2018 | Event News
13.02.2018 | Event News
12.02.2018 | Event News
23.02.2018 | Physics and Astronomy
23.02.2018 | Health and Medicine
23.02.2018 | Physics and Astronomy